Works matching IS 03065251 AND DT 1982 AND VI 14 AND IP 2
1
- British Journal of Clinical Pharmacology, 1982, v. 14, n. 2, p. 294, doi. 10.1111/j.1365-2125.1982.tb01980.x
- Porro, MG;
- Kupferberg, HJ;
- Porter, RJ;
- Theodore, WH;
- Newmark, ME
- Article
2
- British Journal of Clinical Pharmacology, 1982, v. 14, n. 2, p. 201, doi. 10.1111/j.1365-2125.1982.tb01962.x
- Houghton, GW;
- Hundt, HK;
- Muller, FO;
- Templeton, R
- Article
3
- British Journal of Clinical Pharmacology, 1982, v. 14, n. 2, p. 273, doi. 10.1111/j.1365-2125.1982.tb01973.x
- Dixon, PA;
- Oforah, E;
- Makanjuola, R
- Article
4
- British Journal of Clinical Pharmacology, 1982, v. 14, n. 2, p. 306, doi. 10.1111/j.1365-2125.1982.tb01984.x
- Andreasen, F;
- Botker, HE;
- Lorentzen, K
- Article
5
- British Journal of Clinical Pharmacology, 1982, v. 14, n. 2, p. 225, doi. 10.1111/j.1365-2125.1982.tb01966.x
- Ochs, HR;
- Pabst, J;
- Greenblatt, DJ;
- Hartlapp, J
- Article
6
- British Journal of Clinical Pharmacology, 1982, v. 14, n. 2, p. 286, doi. 10.1111/j.1365-2125.1982.tb01977.x
- Adams, KR;
- Halliday, LD;
- Sibeon, RG;
- Baber, N;
- Littler, T;
- Orme, ML
- Article
7
- British Journal of Clinical Pharmacology, 1982, v. 14, n. 2, p. 177, doi. 10.1111/j.1365-2125.1982.tb01959.x
- Article
8
- British Journal of Clinical Pharmacology, 1982, v. 14, n. 2, p. 195, doi. 10.1111/j.1365-2125.1982.tb01961.x
- Hecken, AM;
- Tjandramaga, TB;
- Mullie, A;
- Verbesselt, R;
- Schepper, PJ
- Article
9
- British Journal of Clinical Pharmacology, 1982, v. 14, n. 2, p. 269, doi. 10.1111/j.1365-2125.1982.tb01972.x
- Article
10
- British Journal of Clinical Pharmacology, 1982, v. 14, n. 2, p. 304, doi. 10.1111/j.1365-2125.1982.tb01983.x
- Kelly, JG;
- McGarry, K;
- O'Malley, K;
- O'Brien, ET
- Article
11
- British Journal of Clinical Pharmacology, 1982, v. 14, n. 2, p. 219, doi. 10.1111/j.1365-2125.1982.tb01965.x
- Begg, EJ;
- Chinwah, PM;
- Webb, C;
- Day, RO;
- Wade, DN
- Article
12
- British Journal of Clinical Pharmacology, 1982, v. 14, n. 2, p. 284, doi. 10.1111/j.1365-2125.1982.tb01976.x
- Magnusson, JO;
- Bergdahl, B;
- Bogentoft, C;
- Jonsson, UE
- Article
13
- British Journal of Clinical Pharmacology, 1982, v. 14, n. 2, p. 171, doi. 10.1111/j.1365-2125.1982.tb01958.x
- Article
14
- British Journal of Clinical Pharmacology, 1982, v. 14, n. 2, p. 247, doi. 10.1111/j.1365-2125.1982.tb01969.x
- Kelman, AW;
- Whiting, B;
- Bryson, SM
- Article
15
- British Journal of Clinical Pharmacology, 1982, v. 14, n. 2, p. 187, doi. 10.1111/j.1365-2125.1982.tb01960.x
- Mignon, M;
- Chau, NP;
- Nguyen-Phuoc, BK;
- Sauvage, M;
- Leguy, F;
- Bonfils, S
- Article
16
- British Journal of Clinical Pharmacology, 1982, v. 14, n. 2, p. 265, doi. 10.1111/j.1365-2125.1982.tb01971.x
- Freestone, S;
- Silas, JH;
- Ramsay, LE
- Article
17
- British Journal of Clinical Pharmacology, 1982, v. 14, n. 2, p. 301, doi. 10.1111/j.1365-2125.1982.tb01982.x
- Lennard, MS;
- Silas, JH;
- Freestone, S;
- Trevethick, J
- Article
18
- British Journal of Clinical Pharmacology, 1982, v. 14, n. 2, p. 213, doi. 10.1111/j.1365-2125.1982.tb01964.x
- Maudgal, DP;
- Maxwell, JD;
- Lees, LJ;
- Wild, RN
- Article
19
- British Journal of Clinical Pharmacology, 1982, v. 14, n. 2, p. 282, doi. 10.1111/j.1365-2125.1982.tb01975.x
- Wilkinson, PR;
- Tait, C;
- Hesp, R;
- Raftery, EB
- Article
20
- British Journal of Clinical Pharmacology, 1982, v. 14, n. 2, p. 159, doi. 10.1111/j.1365-2125.1982.tb01957.x
- Article
21
- British Journal of Clinical Pharmacology, 1982, v. 14, n. 2, p. 241, doi. 10.1111/j.1365-2125.1982.tb01968.x
- Simon, AC;
- Levenson, JA;
- Levy, BY;
- Bouthier, JE;
- Peronneau, PP;
- Safar, ME
- Article
22
- British Journal of Clinical Pharmacology, 1982, v. 14, n. 2, p. 292, doi. 10.1111/j.1365-2125.1982.tb01979.x
- Harenberg, J;
- Staiger, C;
- Vries, JX;
- Walter, E;
- Weber, E;
- Zimmermann, R
- Article
23
- British Journal of Clinical Pharmacology, 1982, v. 14, n. 2, p. 257, doi. 10.1111/j.1365-2125.1982.tb01970.x
- Jackson, PR;
- Ramsay, LE;
- Wakefield, V
- Article
24
- British Journal of Clinical Pharmacology, 1982, v. 14, n. 2, p. 298, doi. 10.1111/j.1365-2125.1982.tb01981.x
- Peterson, GM;
- McLean, S;
- Aldous, S;
- Witt, RJ;
- Millingen, KS
- Article
25
- British Journal of Clinical Pharmacology, 1982, v. 14, n. 2, p. 207, doi. 10.1111/j.1365-2125.1982.tb01963.x
- Article
26
- British Journal of Clinical Pharmacology, 1982, v. 14, n. 2, p. 310, doi. 10.1111/j.1365-2125.1982.tb01985.x
- Barnett, DB;
- Hudson, SA;
- McBurney, A
- Article
27
- British Journal of Clinical Pharmacology, 1982, v. 14, n. 2, p. 279, doi. 10.1111/j.1365-2125.1982.tb01974.x
- Rubin, PC;
- Butters, L;
- Low, RA;
- Reid, JL
- Article
28
- British Journal of Clinical Pharmacology, 1982, v. 14, n. 2, p. 231, doi. 10.1111/j.1365-2125.1982.tb01967.x
- Mwaluko, G;
- Weinshilboum, R
- Article
29
- British Journal of Clinical Pharmacology, 1982, v. 14, n. 2, p. 290, doi. 10.1111/j.1365-2125.1982.tb01978.x
- Article